A PYMNTS Company

Australia: Antitrust authority approves new regulations to increase pharma transparency

By  |  January 8, 2013

The Australian Competition and Consumer Commission has given Australia’s pharmaceutical companies a timeline of two years to improve transparency in regards to the companies’ payments and sponsorships to healthcare professionals. While originally sought for a five year acceptance, Medicines Australia’s most recent Code of Conduct has been approved for two years; the new regulations are aimed at ensuring the makers of prescription drugs disclose the doctors and consumer groups they pay.

 

Full Content: PharmaTimes

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.